中文｜English
ISSN 1001-5256 (Print)
ISSN 2097-3497 (Online)
CN 22-1108/R
Volume 41 Issue 5
May  2025
Turn off MathJax
Article Contents
Article Navigation >  Journal of Clinical Hepatology  > 2025  >  41(5): 907-913

Coagulation abnormalities in acute decompensated cirrhosis comorbid with infection： A prospective observational study based on thromboelastography

DOI: 10.12449/JCH250516
  • a.

    Hepatology Center, Nanfang Hospital，Southern Medical University，Guangzhou 510515，China

  • b.

    Department of Intensive Care Unit, Nanfang Hospital，Southern Medical University，Guangzhou 510515，China

Research funding:

National Key Research and Development Program (2022YFC2304800)

More Information
  • Corresponding author: CHEN Jinjun， chjj@smu.edu.cn （ORCID： 0000-0003-4275-9149）
  • Received Date: 2024-05-05
  • Accepted Date: 2024-07-15
  • Published Date: 2025-05-25
    Abstract
  •   Objective  To investigate the changes in coagulation system in acute decompensated cirrhosis （ADC） patients with or without sepsis and the association of these changes with short-term prognosis.  Methods  A prospective study was conducted among 116 ADC patients who were hospitalized in Nanfang Hospital from January 2021 to July 2023， among whom there were 86 patients with sepsis and 30 patients without sepsis， and 54 patients with sepsis alone who had no chronic liver disease were enrolled as control group. Thromboelastography （TEG） and other conventional coagulation parameters were used to comprehensively evaluate the coagulation function of patients. The data including TEG results and short-term prognosis were collected， and a correlation analysis was performed. The independent-samples t test was used for comparison of normally distributed continuous data between two groups， and the Mann-Whitney U test was used for comparison of non-normally distributed continuous data between two groups； the chi-square test was used for comparison of categorical data between two groups. The Spearman correlation coefficient was calculated to investigate the correlation between different variables. The Logistic regression model was used to perform the univariate and multivariate analyses.  Results  For the ADC patients with sepsis， the lungs and bloodstream were the main infection sites， and bacteria were the main pathogenic microorganism. TEG results showed that compared with the patients with sepsis alone， the patients with ADC and sepsis had a significant reduction in median maximum amplitude （MA）， a significant increase in coagulation time （K time）， and a significant reduction in α angle （all P<0.05）； the patients with ADC and sepsis had a significantly longer reaction time （R time） than those with ADC alone （P=0.02）， and the patients with sepsis alone had a significantly longer R time than those with ADC and sepsis （P=0.04）. There was no correlation between MA and platelet count in the patients with ADC and sepsis （r=-0.133， P=0.057）， while there was a significant correlation between MA and platelet count in the patients with sepsis alone （r=0.595， P=0.001）. SOFA score was negatively correlated with MA in sepsis patients with or without ADC （r=-0.503 and -0.561， both P<0.001）， and for the patients with ADC and sepsis， R time， K time， and α angle were weakly correlated with SOFA score and had a relatively strong correlation with APTT （all P<0.05）. The patients with ADC alone all survived within 90 days， and compared with the death group， the patients with sepsis alone who survived had significantly higher values of MA and α angle （all P<0.05）； there was a significant difference in α angle on day 90 between the survival group and the death group， no matter whether the patients were comorbid with ADC or not （both P<0.01）， while for the patients with ADC and sepsis， there was no significant difference in MA value on day 90 between the survival group and the death group （P>0.05）.  Conclusion  For ADC patients comorbid with sepsis， coagulation function assessment and monitoring should be taken seriously in clinical practice， and TEG parameters and SOFA score should be monitored when necessary to develop individualized treatment regimens.

     

    • FullText(HTML)
  • loading
    • References(28)
  • [1]
    MOREAU R, JALAN R, GINES P, et al. Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis[J]. Gastroenterology, 2013, 144( 7): 1426- 1437. DOI: 10.1053/j.gastro.2013.02.042.
    [2]
    BAJAJ JS, O’LEARY JG, RAJENDER REDDY K, et al. Survival in infection-related acute-on-chronic liver failure is defined by extrahepatic organ failures[J]. Hepatology, 2014, 60( 1): 250- 256. DOI: 10.1002/hep.27077.
    [3]
    LISMAN T, HERNANDEZ-GEA V, MAGNUSSON M, et al. The concept of rebalanced hemostasis in patients with liver disease: Communication from the ISTH SSC working group on hemostatic management of patients with liver disease[J]. J Thromb Haemost, 2021, 19( 4): 1116- 1122. DOI: 10.1111/jth.15239.
    [4]
    WONG F, BERNARDI M, BALK R, et al. Sepsis in cirrhosis: Report on the 7th meeting of the International Ascites Club[J]. Gut, 2005, 54( 5): 718- 725. DOI: 10.1136/gut.2004.038679.
    [5]
    FERNÁNDEZ J, ACEVEDO J, WIEST R, et al. Bacterial and fungal infections in acute-on-chronic liver failure: Prevalence, characteristics and impact on prognosis[J]. Gut, 2018, 67( 10): 1870- 1880. DOI: 10.1136/gutjnl-2017-314240.
    [6]
    PLESSIER A, DENNINGER MH, CONSIGNY Y, et al. Coagulation disorders in patients with cirrhosis and severe sepsis[J]. Liver Int, 2003, 23( 6): 440- 448. DOI: 10.1111/j.1478-3231.2003.00870.x.
    [7]
    KUROKAWA T, ZHENG YW, OHKOHCHI N. Novel functions of platelets in the liver[J]. J Gastroenterol Hepatol, 2016, 31( 4): 745- 751. DOI: 10.1111/jgh.13244.
    [8]
    MANDORFER M, SCHWABL P, PATERNOSTRO R, et al. Von Willebrand factor indicates bacterial translocation, inflammation, and procoagulant imbalance and predicts complications independently of portal hypertension severity[J]. Aliment Pharmacol Ther, 2018, 47( 7): 980- 988. DOI: 10.1111/apt.14522.
    [9]
    AFDHAL NH, GIANNINI EG, TAYYAB G, et al. Eltrombopag before procedures in patients with cirrhosis and thrombocytopenia[J]. N Engl J Med, 2012, 367( 8): 716- 724. DOI: 10.1056/NEJMoa1110709.
    [10]
    VINCENT JL, MORENO R, TAKALA J, et al. The SOFA(Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine[J]. Intensive Care Med, 1996, 22( 7): 707- 710. DOI: 10.1007/BF01709751.
    [11]
    KUMAR M, AHMAD J, MAIWALL R, et al. Thromboelastography-guided blood component use in patients with cirrhosis with nonvariceal bleeding: A randomized controlled trial[J]. Hepatology, 2020, 71( 1): 235- 246. DOI: 10.1002/hep.30794.
    [12]
    IBA T, LEVY JH, RAJ A, et al. Advance in the management of sepsis-induced coagulopathy and disseminated intravascular coagulation[J]. J Clin Med, 2019, 8( 5): 728. DOI: 10.3390/jcm8050728.
    [13]
    MÜLLER MC, MEIJERS JCM, VROOM MB, et al. Utility of thromboelastography and/or thromboelastometry in adults with sepsis: A systematic review[J]. Crit Care, 2014, 18( 1): R30. DOI: 10.1186/cc13721.
    [14]
    LUO CZ, HU HB, GONG J, et al. The value of thromboelastography in the diagnosis of sepsis-induced coagulopathy[J]. Clin Appl Thromb Hemost, 2020, 26: 1076029620951847. DOI: 10.1177/1076029620951847.
    [15]
    ANDERSEN MG, HVAS CL, TØNNESEN E, et al. Thromboelastometry as a supplementary tool for evaluation of hemostasis in severe sepsis and septic shock[J]. Acta Anaesthesiol Scand, 2014, 58( 5): 525- 533. DOI: 10.1111/aas.12290.
    [16]
    BAGLIN T. Using the laboratory to predict recurrent venous thrombosis[J]. Int J Lab Hematol, 2011, 33( 4): 333- 342. DOI: 10.1111/j.1751-553X.2011.01345.x.
    [17]
    GIRDAUSKAS E, KEMPFERT J, KUNTZE T, et al. Thromboelastometrically guided transfusion protocol during aortic surgery with circulatory arrest: A prospective, randomized trial[J]. J Thorac Cardiovasc Surg, 2010, 140( 5): 1117- 1124. e 2. DOI: 10.1016/j.jtcvs.2010.04.043.
    [18]
    AKAY OM, USTUNER Z, CANTURK Z, et al. Laboratory investigation of hypercoagulability in cancer patients using rotation thrombelastography[J]. Med Oncol, 2009, 26( 3): 358- 364. DOI: 10.1007/s12032-008-9129-0.
    [19]
    BLASI A, PATEL VC, ADELMEIJER J, et al. Mixed fibrinolytic phenotypes in decompensated cirrhosis and acute-on-chronic liver failure with hypofibrinolysis in those with complications and poor survival[J]. Hepatology, 2020, 71( 4): 1381- 1390. DOI: 10.1002/hep.30915.
    [20]
    JIANG XH, CHAI SQ, HUANG Y, et al. Design for a multicentre prospective cohort for the assessment of platelet function in patients with hepatitis-B-virus-related acute-on-chronic liver failure[J]. Clin Epidemiol, 2022, 14: 997- 1011. DOI: 10.2147/CLEP.S376068.
    [21]
    GU WY, XU BY, ZHENG X, et al. Acute-on-chronic liver failure in China: Rationale for developing a patient registry and baseline characteristics[J]. Am J Epidemiol, 2018, 187( 9): 1829- 1839. DOI: 10.1093/aje/kwy083.
    [22]
    QIAO L, WANG XB, DENG GH, et al. Cohort profile: A multicentre prospective validation cohort of the Chinese Acute-on-Chronic Liver Failure(CATCH-LIFE) study[J]. BMJ Open, 2021, 11( 1): e037793. DOI: 10.1136/bmjopen-2020-037793.
    [23]
    ELTING LS, RUBENSTEIN EB, MARTIN CG, et al. Incidence, cost, and outcomes of bleeding and chemotherapy dose modification among solid tumor patients with chemotherapy-induced thrombocytopenia[J]. J Clin Oncol, 2001, 19( 4): 1137- 1146. DOI: 10.1200/JCO.2001.19.4.1137.
    [24]
    SARIN SK, CHOUDHURY A, SHARMA MK, et al. Acute-on-chronic liver failure: Consensus recommendations of the Asian Pacific association for the study of the liver(APASL): An update[J]. Hepatol Int, 2019, 13( 4): 353- 390. DOI: 10.1007/s12072-019-09946-3.
    [25]
    CHOUDHURY A, KUMAR M, SHARMA BC, et al. Systemic inflammatory response syndrome in acute-on-chronic liver failure: Relevance of‘golden window’: A prospective study[J]. J Gastroenterol Hepatol, 2017, 32( 12): 1989- 1997. DOI: 10.1111/jgh.13799.
    [26]
    HERBSTREIT F, WINTER EM, PETERS J, et al. Monitoring of haemostasis in liver transplantation: Comparison of laboratory based and point of care tests[J]. Anaesthesia, 2010, 65( 1): 44- 49. DOI: 10.1111/j.1365-2044.2009.06159.x.
    [27]
    ZHOU WY, ZHOU WJ, BAI JJ, et al. TEG in the monitoring of coagulation changes in patients with sepsis and the clinical significance[J]. Exp Ther Med, 2019, 17( 5): 3373- 3382. DOI: 10.3892/etm.2019.7342.
    [28]
    PREMKUMAR M, MEHTANI R, DIVYAVEER S, et al. Clinical validation of global coagulation tests to guide blood component transfusions in cirrhosis and ACLF[J]. J Clin Transl Hepatol, 2021, 9( 2): 210- 219. DOI: 10.14218/JCTH.2020.00121.
    • Relative Articles
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(5)  / Tables(4)

    Get Citation
    PDF
    XML

    Article Metrics

    Article views (453) PDF downloads(34) Cited by()
    Proportional views
    Related
        

    The first journal specializing in hepatobiliary and pancreatic diseases in China

    Supervisor：Ministry of Education of the People's Republic of China

    Sponsor：Jilin University

    Academic Support: Chinese Society of Hepatology，Chinese Medical Association

    Address: 461 Xinjiang Road, Changchun

    Submit：0431-88782044

    Peer review：0431-88783542

    Email：lcgdb@vip.163.com

    About Journal

    Submission Guideline

    Journal Online

    Hepatobiliary College

    Guidelines

    YesterdayIP[]YesterdayPV[]TodayIP[]TodayPV[]Online[]

    Website Design © 2020 Editorial Board of Journal of Clinical Hepatology 吉ICP备10000617号-1 Supported by: Beijing Renhe Information Technology Co. Ltd  

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return